| Primary | 
									
											
										
											| Coronary Artery Disease | 40.0% |  
											| Cardiac Failure Congestive | 20.0% |  
											| Type 2 Diabetes Mellitus | 20.0% |  
											| Hypercholesterolaemia | 13.3% |  
											| Hypertension | 6.7% |  |  | 
							
						
							| Secondary | 
									
											
										
											| Product Used For Unknown Indication | 16.6% |  
											| Coronary Artery Disease | 11.4% |  
											| Acute Coronary Syndrome | 10.9% |  
											| Hypertension | 10.4% |  
											| Atrial Fibrillation | 4.7% |  
											| Diabetic Retinopathy | 4.7% |  
											| Myocardial Ischaemia | 4.7% |  
											| Hypotension | 4.1% |  
											| Renal Failure | 4.1% |  
											| Bronchopneumonia | 3.6% |  
											| Diabetes Mellitus | 3.6% |  
											| Hyperlipidaemia | 3.6% |  
											| Drug-induced Liver Injury | 3.1% |  
											| Pyrexia | 3.1% |  
											| Type 2 Diabetes Mellitus | 2.6% |  
											| Sepsis | 2.1% |  
											| Thrombosis Prophylaxis | 2.1% |  
											| Anaemia | 1.6% |  
											| Benign Prostatic Hyperplasia | 1.6% |  
											| Cardiac Failure | 1.6% |  | 
									
											
										
											| Cardiogenic Shock | 18.8% |  
											| Duodenal Ulcer Haemorrhage | 18.8% |  
											| Pulmonary Embolism | 12.5% |  
											| Rectal Cancer | 12.5% |  
											| Renal Failure Acute | 12.5% |  
											| Shock Haemorrhagic | 12.5% |  
											| Drug Prescribing Error | 6.3% |  
											| Traumatic Haematoma | 6.3% |  | 
							
						
							| Concomitant | 
									
											
										
											| Product Used For Unknown Indication | 32.2% |  
											| Hypertension | 12.0% |  
											| Drug Use For Unknown Indication | 8.8% |  
											| Parkinson's Disease | 5.2% |  
											| Myocardial Ischaemia | 4.8% |  
											| Prophylaxis | 4.6% |  
											| Rheumatoid Arthritis | 4.5% |  
											| Osteoporosis | 3.8% |  
											| Type 2 Diabetes Mellitus | 3.2% |  
											| Thrombosis Prophylaxis | 2.6% |  
											| Cardiac Failure | 2.0% |  
											| Glaucoma | 2.0% |  
											| Hypercholesterolaemia | 2.0% |  
											| Hyperlipidaemia | 2.0% |  
											| Metabolic Disorder | 2.0% |  
											| Ill-defined Disorder | 1.9% |  
											| Hyperuricaemia | 1.7% |  
											| Myeloma Recurrence | 1.7% |  
											| Anticoagulant Therapy | 1.4% |  
											| Ischaemia | 1.3% |  | 
									
											
										
											| Death | 7.5% |  
											| Ventricular Extrasystoles | 7.5% |  
											| Vomiting | 7.5% |  
											| Cardiac Failure | 6.3% |  
											| Renal Failure Acute | 6.3% |  
											| Sepsis | 6.3% |  
											| Wegener's Granulomatosis | 6.3% |  
											| Aortic Aneurysm | 5.0% |  
											| Atrial Fibrillation | 5.0% |  
											| Jaundice Cholestatic | 5.0% |  
											| Myocardial Infarction | 5.0% |  
											| Renal Failure | 5.0% |  
											| Fall | 3.8% |  
											| Hypertension | 3.8% |  
											| Pain In Extremity | 3.8% |  
											| Proctitis | 3.8% |  
											| Pyrexia | 3.8% |  
											| Urticaria | 3.8% |  
											| Bronchopneumonia | 2.5% |  
											| Cardiopulmonary Failure | 2.5% |  |